---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-021113"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T01:21:54.904552+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ensysce Biosciences regains compliance with Nasdaq equity requirement on June 13

## Summary
- Received formal notice from Nasdaq that it now meets the equity requirement under Listing Rule 5550(b)(1).
- The Nasdaq Hearings Panel matter concerning listing compliance has been closed.
- Ensysce common stock (ENSC) will continue trading on the Nasdaq Capital Market.
- Company cautioned that future compliance with all Nasdaq requirements is not guaranteed.

## SEC filing metadata
- accession: 0001493152-23-021113
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315223021113/0001493152-23-021113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315223021113/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-021113
- JSON: https://secwatch.observer/filing/0001493152-23-021113.json
- Plain text: https://secwatch.observer/filing/0001493152-23-021113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.